Description
CNP-PTX, or Paclitaxel encapsulated in Carbon Nano Particles, is an innovative nanocarrier system designed for enhanced cancer treatment. By encapsulating paclitaxel, a widely used chemotherapeutic agent, in carbon nanoparticles, this system improves drug solubility, stability, and targeted delivery to tumor cells. The CNP-PTX formulation minimizes systemic toxicity while increasing the therapeutic efficacy of paclitaxel, making it a valuable tool in oncology. Its nanostructure allows for controlled drug release, offering a promising approach for more effective cancer therapies.
